BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3140421)

  • 1. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of benzylamine oxidase from cultured porcine aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Biochem Cell Biol; 1988 Aug; 66(8):821-9. PubMed ID: 2848544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [14C] allylamine to isolated mitochondria from rat heart and aorta.
    Hysmith RM; Boor PJ
    Toxicology; 1987 Apr; 44(1):13-29. PubMed ID: 3105119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells.
    Hysmith RM; Boor PJ
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):668-74. PubMed ID: 2442532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
    Kumar D; Trent MB; Boor PJ
    Toxicology; 1998 Feb; 125(2-3):107-15. PubMed ID: 9570326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative study of cardiovascular toxins utilizing a sensitive indicator of sublethal toxic injury.
    Hysmith RH; Welch TK; Boor PJ
    In Vitro Cell Dev Biol; 1987 Feb; 23(2):129-33. PubMed ID: 3818504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzylamine oxidase activity in spontaneously hypertensive rats.
    Hayes BE; Clarke DE
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):137-40. PubMed ID: 3983466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues.
    Lewinsohn R
    Braz J Med Biol Res; 1984; 17(3-4):223-56. PubMed ID: 6442176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative toxicity of the cardiovascular toxin allylamine to porcine aortic smooth muscle and endothelial cells.
    Hysmith RM; Boor PJ
    Toxicology; 1986 Feb; 38(2):141-50. PubMed ID: 3945966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allylamine cardiovascular toxicity: VI. Subcellular distribution in rat aortas.
    Hysmith RM; Boor PJ
    Toxicology; 1985 Jun; 35(3):179-87. PubMed ID: 2990070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in benzylamine oxidase activity in rat tissues.
    Cao Danh H; Strolin Benedetti M; Dostert P; Mousset A
    J Pharm Pharmacol; 1984 Sep; 36(9):592-6. PubMed ID: 6149282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
    Boor PJ; Nelson TJ
    Toxicology; 1980; 18(2):87-102. PubMed ID: 7256782
    [No Abstract]   [Full Text] [Related]  

  • 17. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
    Awasthi S; Boor PJ
    Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of semicarbazide-sensitive amine oxidase from porcine aorta.
    Tipnis UR; Tao M; Boor PJ
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):575-84. PubMed ID: 1483111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
    Conklin DJ; Langford SD; Boor PJ
    Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzylamine oxidase in normal and atherosclerotic human aortae.
    Hayes BE; Ostrow PT; Clarke DE
    Exp Mol Pathol; 1983 Apr; 38(2):243-54. PubMed ID: 6832347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.